ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer (2022)
Chaves, Luiz Paulo; Caliari, André Luiz; Lautert-Dutra, William ; Silva, Francisco Cesar de Sousa e ; Melo, Camila Morais; Saggioro, Fabiano Pinto; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Fonte: Cancer Research. Nome do evento: AACR Annual Meeting. Unidade: FMRP
Assuntos: IMUNOLOGIA CELULAR, NEOPLASIAS, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Luiz Paulo et al. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2022-6098. Acesso em: 25 set. 2024. , 2022
APA
Chaves, L. P., Caliari, A. L., Lautert-Dutra, W., Silva, F. C. de S. e, Melo, C. M., Saggioro, F. P., et al. (2022). Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.AM2022-6098
NLM
Chaves LP, Caliari AL, Lautert-Dutra W, Silva FC de S e, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 set. 25 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6098
Vancouver
Chaves LP, Caliari AL, Lautert-Dutra W, Silva FC de S e, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer [Internet]. Cancer Research. 2022 ; 82( 12):[citado 2024 set. 25 ] Available from: https://doi.org/10.1158/1538-7445.AM2022-6098
Artigo de periodico
Obesity influence on bladder inflammation and cancer: a cystitis model (2022)
Andrade, Cristiano Trindade de; Rocha, Guilherme Zweig; Zamuner, Marina; Reis, Rodolfo Borges dos ; Reis, Leonardo Oliveira
Fonte: International Journal of Clinical and Experimental Pathology. Unidade: FMRP
Assuntos: INFLAMAÇÃO, OBESIDADE, CISTITE, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Cristiano Trindade de et al. Obesity influence on bladder inflammation and cancer: a cystitis model. International Journal of Clinical and Experimental Pathology, v. 15, n. 9, p. 373–379, 2022Tradução . . Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547991/. Acesso em: 25 set. 2024.
APA
Andrade, C. T. de, Rocha, G. Z., Zamuner, M., Reis, R. B. dos, & Reis, L. O. (2022). Obesity influence on bladder inflammation and cancer: a cystitis model. International Journal of Clinical and Experimental Pathology, 15( 9), 373–379. Recuperado de https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547991/
NLM
Andrade CT de, Rocha GZ, Zamuner M, Reis RB dos, Reis LO. Obesity influence on bladder inflammation and cancer: a cystitis model [Internet]. International Journal of Clinical and Experimental Pathology. 2022 ; 15( 9): 373–379.[citado 2024 set. 25 ] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547991/
Vancouver
Andrade CT de, Rocha GZ, Zamuner M, Reis RB dos, Reis LO. Obesity influence on bladder inflammation and cancer: a cystitis model [Internet]. International Journal of Clinical and Experimental Pathology. 2022 ; 15( 9): 373–379.[citado 2024 set. 25 ] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547991/
Trabalho de evento-resumo
Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer (2021)
Souza, Luiz Paulo Chaves de; Costa, André Luiz Caliari ; Dutra, William Lautert; Melo, Camila Morais ; Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago; Saggioro, Fabiano Pinto; Reis, Rodolfo Borges dos; Squire, Jeremy Andrew
Fonte: Resumos. Nome do evento: Congresso Brasileiro de Genética = Brazilian Congress of Genetics. Unidades: SVOI, FMRP
Assuntos: TRANSCRIÇÃO, NEOPLASIAS, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. 2021, Anais.. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG, 2021. Disponível em: https://www.sbg.org.br/anais. Acesso em: 25 set. 2024.
APA
Souza, L. P. C. de, Costa, A. L. C., Dutra, W. L., Melo, C. M., Albuquerque, C. G. P. de, Vidotto, T., et al. (2021). Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. In Resumos. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG. Recuperado de https://www.sbg.org.br/anais
NLM
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 set. 25 ] Available from: https://www.sbg.org.br/anais
Vancouver
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 set. 25 ] Available from: https://www.sbg.org.br/anais
Artigo de periodico
Emerging role of PTEN loss in evasion of the immune response to tumours (2020)
Vidotto, Thiago ; Melo, Camila Morais ; Castelli, Erick C. ; Koti, Madhuri ; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Fonte: British Journal of Cancer. Unidade: FMRP
Assuntos: GENÉTICA, NEOPLASIAS, BIOMARCADORES, IMUNOTERAPIA, MUTAÇÃO, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer, v. 122, p. 1732-1743, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41416-020-0834-6. Acesso em: 25 set. 2024.
APA
Vidotto, T., Melo, C. M., Castelli, E. C., Koti, M., Reis, R. B. dos, & Squire, J. A. (2020). Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer, 122, 1732-1743. doi:10.1038/s41416-020-0834-6
NLM
Vidotto T, Melo CM, Castelli EC, Koti M, Reis RB dos, Squire JA. Emerging role of PTEN loss in evasion of the immune response to tumours [Internet]. British Journal of Cancer. 2020 ; 122 1732-1743.[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/s41416-020-0834-6
Vancouver
Vidotto T, Melo CM, Castelli EC, Koti M, Reis RB dos, Squire JA. Emerging role of PTEN loss in evasion of the immune response to tumours [Internet]. British Journal of Cancer. 2020 ; 122 1732-1743.[citado 2024 set. 25 ] Available from: https://doi.org/10.1038/s41416-020-0834-6
Artigo de periodico
Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) (2020)
Jamaspishvili, Tamara; Patel, Palak G; Niu, Yi; Vidotto, Thiago; Caven, Isabelle; Livergant, Rachel; Fu, Winnie; Kawashima, Atsunari; How, Nathan; Okello, John B.; Guedes, Liana B.; Ouellet, Veronique; Picanço, Clarissa; Koti, Madhuri; Reis, Rodolfo Borges dos ; Saad, Fred; Mes-Masson, Anne-Marie; Lotan, Tamara L; Squire, Jeremy Andrew ; Peng, Yingwei P.; Siemens, D. Robert; Berman, David M.
Fonte: JNCI: Journal of the National Cancer Institute. Unidade: FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, PROSTATECTOMIA, IMUNOHISTOQUÍMICA, ANÁLISE EM MICROSSÉRIES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAMASPISHVILI, Tamara et al. Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN). JNCI: Journal of the National Cancer Institute, v. 112, n. 11, p. 1098-1104, 2020Tradução . . Disponível em: https://doi.org/10.1093/jnci/djaa032. Acesso em: 25 set. 2024.
APA
Jamaspishvili, T., Patel, P. G., Niu, Y., Vidotto, T., Caven, I., Livergant, R., et al. (2020). Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN). JNCI: Journal of the National Cancer Institute, 112( 11), 1098-1104. doi:10.1093/jnci/djaa032
NLM
Jamaspishvili T, Patel PG, Niu Y, Vidotto T, Caven I, Livergant R, Fu W, Kawashima A, How N, Okello JB, Guedes LB, Ouellet V, Picanço C, Koti M, Reis RB dos, Saad F, Mes-Masson A-M, Lotan TL, Squire JA, Peng YP, Siemens DR, Berman DM. Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) [Internet]. JNCI: Journal of the National Cancer Institute. 2020 ; 112( 11): 1098-1104.[citado 2024 set. 25 ] Available from: https://doi.org/10.1093/jnci/djaa032
Vancouver
Jamaspishvili T, Patel PG, Niu Y, Vidotto T, Caven I, Livergant R, Fu W, Kawashima A, How N, Okello JB, Guedes LB, Ouellet V, Picanço C, Koti M, Reis RB dos, Saad F, Mes-Masson A-M, Lotan TL, Squire JA, Peng YP, Siemens DR, Berman DM. Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) [Internet]. JNCI: Journal of the National Cancer Institute. 2020 ; 112( 11): 1098-1104.[citado 2024 set. 25 ] Available from: https://doi.org/10.1093/jnci/djaa032
Artigo de periodico
Investigation of sweat VOC profiles in assessment of cancer biomarkers using HS-GC-MS (2020)
Monedeiro, Fernanda; Reis, Rodolfo Borges dos ; Peria, Fernanda Maris ; Sares, Cláudia Tarcila Gomes; De Martinis, Bruno Spinosa
Fonte: Journal of Breath Research. Unidades: FMRP, FFCLRP
Assuntos: NEOPLASIAS, ESTUDOS DE CASOS E CONTROLES, CROMATOGRAFIA A GÁS, ESPECTROMETRIA DE MASSAS, COMPOSTOS ORGÂNICOS, COMPOSTOS VOLÁTEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONEDEIRO, Fernanda et al. Investigation of sweat VOC profiles in assessment of cancer biomarkers using HS-GC-MS. Journal of Breath Research, v. 14, n. 2, 2020Tradução . . Disponível em: https://doi.org/10.1088/1752-7163/ab5b3c. Acesso em: 25 set. 2024.
APA
Monedeiro, F., Reis, R. B. dos, Peria, F. M., Sares, C. T. G., & De Martinis, B. S. (2020). Investigation of sweat VOC profiles in assessment of cancer biomarkers using HS-GC-MS. Journal of Breath Research, 14( 2). doi:10.1088/1752-7163/ab5b3c
NLM
Monedeiro F, Reis RB dos, Peria FM, Sares CTG, De Martinis BS. Investigation of sweat VOC profiles in assessment of cancer biomarkers using HS-GC-MS [Internet]. Journal of Breath Research. 2020 ; 14( 2):[citado 2024 set. 25 ] Available from: https://doi.org/10.1088/1752-7163/ab5b3c
Vancouver
Monedeiro F, Reis RB dos, Peria FM, Sares CTG, De Martinis BS. Investigation of sweat VOC profiles in assessment of cancer biomarkers using HS-GC-MS [Internet]. Journal of Breath Research. 2020 ; 14( 2):[citado 2024 set. 25 ] Available from: https://doi.org/10.1088/1752-7163/ab5b3c
Trabalho de evento-resumo periodico
Quantitative measurement of PTEN loss improves risk assessment in prostate cancer (2019)
Jamaspishvili, Tamara; Patel, Palak; Yi Niu, Dalian; Vidotto, Thiago; Caven, Isabelle; Livergant, Rachel; Fu, Winnie; Ouellet, Veronique; Picanço, Clarissa; Koti, Madhuri; How, Nathan; Saad, Fred; Mes-Masson, Anne-Marie; Lotan, Tamara; Squire, Jeremy Andrew ; Peng, Yingwei; Berman, David; Reis, Rodolfo Borges dos
Fonte: The Journal of Urology. Nome do evento: Annual Meeting American Urological Association -AUA. Unidade: FMRP
Assuntos: NEOPLASIAS, PRÓSTATA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAMASPISHVILI, Tamara et al. Quantitative measurement of PTEN loss improves risk assessment in prostate cancer. The Journal of Urology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/01.JU.0000555707.15264.f6. Acesso em: 25 set. 2024. , 2019
APA
Jamaspishvili, T., Patel, P., Yi Niu, D., Vidotto, T., Caven, I., Livergant, R., et al. (2019). Quantitative measurement of PTEN loss improves risk assessment in prostate cancer. The Journal of Urology. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1097/01.JU.0000555707.15264.f6
NLM
Jamaspishvili T, Patel P, Yi Niu D, Vidotto T, Caven I, Livergant R, Fu W, Ouellet V, Picanço C, Koti M, How N, Saad F, Mes-Masson A-M, Lotan T, Squire JA, Peng Y, Berman D, Reis RB dos. Quantitative measurement of PTEN loss improves risk assessment in prostate cancer [Internet]. The Journal of Urology. 2019 ; 201 e403.[citado 2024 set. 25 ] Available from: https://doi.org/10.1097/01.JU.0000555707.15264.f6
Vancouver
Jamaspishvili T, Patel P, Yi Niu D, Vidotto T, Caven I, Livergant R, Fu W, Ouellet V, Picanço C, Koti M, How N, Saad F, Mes-Masson A-M, Lotan T, Squire JA, Peng Y, Berman D, Reis RB dos. Quantitative measurement of PTEN loss improves risk assessment in prostate cancer [Internet]. The Journal of Urology. 2019 ; 201 e403.[citado 2024 set. 25 ] Available from: https://doi.org/10.1097/01.JU.0000555707.15264.f6
Artigo de periodico
PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells (2019)
Vidotto, Thiago ; Saggioro, Fabiano Pinto ; Jamaspishvili, Tamara; Chesca, Deise Lúcia; Albuquerque, Clarissa Gondim Picanço de; Reis, Rodolfo Borges dos ; Graham, Charles H.; Berman, David M.; Siemens, D. Robert; Squire, Jeremy Andrew ; Koti, Madhuri
Fonte: The Prostate. Unidades: SVOI, FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, SISTEMA IMUNE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, v. 79, n. 9, p. 969-979, 2019Tradução . . Disponível em: https://doi.org/10.1002/pros.23808. Acesso em: 25 set. 2024.
APA
Vidotto, T., Saggioro, F. P., Jamaspishvili, T., Chesca, D. L., Albuquerque, C. G. P. de, Reis, R. B. dos, et al. (2019). PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, 79( 9), 969-979. doi:10.1002/pros.23808
NLM
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/pros.23808
Vancouver
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 set. 25 ] Available from: https://doi.org/10.1002/pros.23808
Artigo de periodico
Cyclin D1 expression in prostate carcinoma (2014)
Pereira, R. A; Ravinal, R. C; Costa, Roberto Silva; Lima, M. S.; Tucci Júnior, Silvio; Muglia, Valdir Antonio; Reis, Rodolfo Borges dos; Silva, Gyl Eanes Barros
Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: NEOPLASIAS, PRÓSTATA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, R. A et al. Cyclin D1 expression in prostate carcinoma. Brazilian Journal of Medical and Biological Research, v. 47, n. 6, p. 515-521, 2014Tradução . . Disponível em: https://doi.org/10.1590/1414-431X20143240. Acesso em: 25 set. 2024.
APA
Pereira, R. A., Ravinal, R. C., Costa, R. S., Lima, M. S., Tucci Júnior, S., Muglia, V. A., et al. (2014). Cyclin D1 expression in prostate carcinoma. Brazilian Journal of Medical and Biological Research, 47( 6), 515-521. doi:10.1590/1414-431X20143240
NLM
Pereira RA, Ravinal RC, Costa RS, Lima MS, Tucci Júnior S, Muglia VA, Reis RB dos, Silva GEB. Cyclin D1 expression in prostate carcinoma [Internet]. Brazilian Journal of Medical and Biological Research. 2014 ; 47( 6): 515-521.[citado 2024 set. 25 ] Available from: https://doi.org/10.1590/1414-431X20143240
Vancouver
Pereira RA, Ravinal RC, Costa RS, Lima MS, Tucci Júnior S, Muglia VA, Reis RB dos, Silva GEB. Cyclin D1 expression in prostate carcinoma [Internet]. Brazilian Journal of Medical and Biological Research. 2014 ; 47( 6): 515-521.[citado 2024 set. 25 ] Available from: https://doi.org/10.1590/1414-431X20143240
Artigo de periodico
Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis (2014)
Botrel, Tobias Engel Ayer; Clark, Otávio; Reis, Rodolfo Borges dos; Pompeo, Antonio Carlos Lima; Ferreira, Ubirajara; Sadi, Marcus Vinicius; Bretas, Francisco Flávio Horta
Fonte: BMC Urology. Unidade: FMRP
Assuntos: ANDRÓGENOS, PRÓSTATA, NEOPLASIAS, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOTREL, Tobias Engel Ayer et al. Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis. BMC Urology, v. 14, 2014Tradução . . Disponível em: https://doi.org/10.1186/1471-2490-14-9. Acesso em: 25 set. 2024.
APA
Botrel, T. E. A., Clark, O., Reis, R. B. dos, Pompeo, A. C. L., Ferreira, U., Sadi, M. V., & Bretas, F. F. H. (2014). Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis. BMC Urology, 14. doi:10.1186/1471-2490-14-9
NLM
Botrel TEA, Clark O, Reis RB dos, Pompeo ACL, Ferreira U, Sadi MV, Bretas FFH. Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis [Internet]. BMC Urology. 2014 ; 14[citado 2024 set. 25 ] Available from: https://doi.org/10.1186/1471-2490-14-9
Vancouver
Botrel TEA, Clark O, Reis RB dos, Pompeo ACL, Ferreira U, Sadi MV, Bretas FFH. Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis [Internet]. BMC Urology. 2014 ; 14[citado 2024 set. 25 ] Available from: https://doi.org/10.1186/1471-2490-14-9

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada